EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark LARPRUVO was filed as Word mark on 03/23/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/26/2016.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 015269459 |
| Application date | March 23, 2016 |
| Publication date | June 17, 2016 |
| Entry date | September 26, 2016 |
| Expiration date | March 23, 2026 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and /or treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia; pharmaceutical preparations for the diagnosis, prevention and /or treatment of dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and /or treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease; pharmaceutical preparations for the diagnosis, prevention and /or treatment of psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11015269459